Patient Portal

David G. Mutch, MD

Ira C. and Judith Gall Professor of Obstetrics and Gynecology
Division of Gynecologic Oncology
Vice Chair, Gynecology

Fellowship Director, Gynecologic Oncology

Specialty Areas

Gynecologic Oncology
Cervical Cancer
Ovarian Cancer
Endometrial Cancer

Board Certifications

Gynecologic Oncology
Obstetrics and Gynecology

Hospital Affiliations

Barnes-Jewish Hospital
Barnes-Jewish West County Hospital
Missouri Baptist Medical Center
St. Louis Children's Hospital

Areas of Clinical Interest

Gynecologic oncology, endometrial cancer, vulva carcinoma, ovarian cancer, cervical cancer, adnexal masses, tumors, hysterectomy, lymphadenectomy, endometrial adenocarcinomas, cervical intraepithelial neoplasia, gynecologic malignancies, ob/gyn, women's health

  • Location(s)
  • Education
  • Publication & Research
  • Financial Disclosures

Location(s)

Location(s)

Missouri Baptist Medical Center
Building D

3023 N. Ballas Road
Fourth Floor, Suite 450
St. Louis, MO 63131

Office Phone: 314-996-6075
Fax: 314-996-6074

Center for Advanced Medicine
Gynecologic Treatment Center

4921 Parkview Place
St. Louis, MO 63110

Suite: C
Floor: 13
Office Phone: 314-362-3181
Fax: 866-282-1113

Education

Education

Fellowship: Gynecologic Oncology, Duke University Medical Center, Durham, North Carolina 1987
Residency: Obstetrics and Gynecology, Washington University School of Medicine, St. Louis, Missouri 1984
Medical Degree: Washington University School of Medicine, St. Louis, Missouri 1980
B.A.: Carleton College, Northfield, Minnesota 1976

Publication & Research

Publication & Research

FIGO 2018 staging criteria for cervical cancer: Impact on stage migration and survival.
Grigsby PW, Massad LS, Mutch DG, Powell MA, Thaker PH, McCourt C, Hagemann A, Fuh K, Kuroki L, Schwarz JK, Markovina S, Lin AJ, Dehdashti F, Siegel BA
Gynecol Oncol. 2020 Apr 2; pii: S0090-8258(20)30252-3. doi: 10.1016/j.ygyno.2020.03.027.

PMID:
    32248993
    [PubMed - as supplied by publisher]
Related citations


Modified frailty index is predictive of wound complications in obese patients undergoing gynecologic surgery via a midline vertical incision.
Mullen MM, Porcelli BP, Cripe J, Massad LS, Kuroki LM, Novetsky AP, Wan L, Powell MA, Mutch DG, Thaker PH
Gynecol Oncol. 2020 Apr; 157(1)287-292. doi: 10.1016/j.ygyno.2019.11.008.

PMID:
    32001077
    [PubMed - in process]
Related citations


Low rates of cascade genetic testing among families with hereditary gynecologic cancer: An opportunity to improve cancer prevention.
Griffin NE, Buchanan TR, Smith SH, Leon AA, Meyer MF, Liu J, Tabak RG, Fuh KC, Thaker PH, Powell MA, Mutch DG, Massad LS, Colditz GA, Hagemann AR
Gynecol Oncol. 2020 Jan; 156(1)140-146. doi: 10.1016/j.ygyno.2019.11.005.

PMID:
    31780235
    [PubMed - indexed for MEDLINE]
Related citations


Optical Resolution Photoacoustic Microscopy of Ovary and Fallopian Tube.
Rao B, Leng X, Zeng Y, Lin Y, Chen R, Zhou Q, Hagemann AR, Kuroki LM, McCourt CK, Mutch DG, Powell MA, Hagemann IS, Zhu Q
Sci Rep. 2019 Oct 4; 9(1)14306. doi: 10.1038/s41598-019-50743-7.

PMID:
    31586106
    [PubMed - in process]
Related citations


Impact of tumor histology on detection of pelvic and para-aortic nodal metastasis with <sup>18</sup>F-fluorodeoxyglucose-positron emission tomography in stage IB cervical cancer.
Lin AJ, Wright JD, Dehdashti F, Siegel BA, Markovina S, Schwarz J, Thaker PH, Mutch DG, Powell MA, Grigsby PW
Int J Gynecol Cancer. 2019 Nov; 29(9)1351-1354. doi: 10.1136/ijgc-2019-000528.

PMID:
    31473660
    [PubMed - in process]
Related citations


Patients with endometrial cancer continue to lack understanding of their risks for cancer.
Sekhon S, Massad LS, Hagemann AR, Dick R, Leon A, Zamorano AS, Thaker PH, McCourt CK, Mutch DG, Powell MA, Kuroki LM
Gynecol Oncol Rep. 2019 Aug; 29106-110. doi: 10.1016/j.gore.2019.07.013.

PMID:
    31467962
    [PubMed]
Related citations


Risk of cervical and vaginal dysplasia after surgery for vulvar intraepithelial neoplasia or cancer: A 6 year follow-up study.
Buchanan TR, Zamorano AS, Massad LS, Liu J, Thaker PH, Powell MA, Mutch DG, Kuroki LM
Gynecol Oncol. 2019 Oct; 155(1)88-92. doi: 10.1016/j.ygyno.2019.07.017.

PMID:
    31375270
    [PubMed - indexed for MEDLINE]
Related citations


Histogram analysis of en face scattering coefficient map predicts malignancy in human ovarian tissue.
Zeng Y, Nandy S, Rao B, Li S, Hagemann AR, Kuroki LK, McCourt C, Mutch DG, Powell MA, Hagemann IS, Zhu Q
J Biophotonics. 2019 Nov; 12(11)e201900115. doi: 10.1002/jbio.201900115.

PMID:
    31304678
    [PubMed - in process]
Related citations


Type II endometrial cancers with minimal, non-invasive residual disease on final pathology: What should we do next?
Mills KA, Lopez H, Sun L, Cripe JC, Litz T, Thaker PH, Powell MA, Mutch DG, Fuh KC
Gynecol Oncol Rep. 2019 Aug; 2920-24. doi: 10.1016/j.gore.2019.05.007.

PMID:
    31193699
    [PubMed]
Related citations


Treatment Compliance as a Major Barrier to Optimal Cervical Cancer Treatment in Guatemala.
Zamorano AS, Barnoya J, Gharzouzi E, Chrisman Robbins C, Orozco E, Polo Guerra S, Mutch DG
J Glob Oncol. 2019 May; 51-5. doi: 10.1200/JGO.18.00243.

PMID:
    31067142
    [PubMed - in process]
Related citations


Do gynecologic oncology patients with severely diminished renal function and urinary tract obstruction benefit from ureteral stenting or percutaneous nephrostomy?
Liang B, Lange SS, Massad LS, Dick R, Mills KA, Hagemann AR, McCourt CK, Thaker PH, Fuh KC, Mutch DG, Powell MA, Kuroki LM
Gynecol Oncol Rep. 2019 May; 28136-140. doi: 10.1016/j.gore.2019.04.007.

PMID:
    31061871
    [PubMed]
Related citations


SOX11 hypermethylation as a tumor biomarker in endometrial cancer.
Shan T, Uyar DS, Wang LS, Mutch DG, Huang TH, Rader JS, Sheng X, Huang YW
Biochimie. 2019 Jul; 1628-14. doi: 10.1016/j.biochi.2019.03.019.

PMID:
    30935961
    [PubMed - indexed for MEDLINE]
Related citations


Dicer1 Phosphomimetic Promotes Tumor Progression and Dissemination.
Aryal NK, Pant V, Wasylishen AR, Rimel BJ, Baseler L, El-Naggar AK, Mutch DG, Goodfellow PJ, Arur S, Lozano G
Cancer Res. 2019 May 15; 79(10)2662-2668. doi: 10.1158/0008-5472.CAN-18-2460.

PMID:
    30914430
    [PubMed - indexed for MEDLINE]
Related citations


Clinical outcomes after isolated pelvic failure in cervical cancer patients treated with definitive radiation.
Lin AJ, Ma S, Markovina S, Schwarz J, Mutch DG, Powell MA, Grigsby PW
Gynecol Oncol. 2019 Jun; 153(3)530-534. doi: 10.1016/j.ygyno.2019.03.104.

PMID:
    30905434
    [PubMed - indexed for MEDLINE]
Related citations


p5RHH nanoparticle-mediated delivery of AXL siRNA inhibits metastasis of ovarian and uterine cancer cells in mouse xenografts.
Mills KA, Quinn JM, Roach ST, Palisoul M, Nguyen M, Noia H, Guo L, Fazal J, Mutch DG, Wickline SA, Pan H, Fuh KC
Sci Rep. 2019 Mar 18; 9(1)4762. doi: 10.1038/s41598-019-41122-3.

PMID:
    30886159
    [PubMed - in process]
Related citations


Wound Complication Rates After Vulvar Excisions for Premalignant Lesions.
Mullen MM, Merfeld EC, Palisoul ML, Massad LS, Woolfolk C, Powell MA, Mutch DG, Thaker PH, Hagemann AR, Kuroki LM
Obstet Gynecol. 2019 Apr; 133(4)658-665. doi: 10.1097/AOG.0000000000003185.

PMID:
    30870300
    [PubMed - indexed for MEDLINE]
Related citations


Targeted metabolomic profiling of low and high grade serous epithelial ovarian cancer tissues: a pilot study.
Garg G, Yilmaz A, Kumar P, Turkoglu O, Mutch DG, Powell MA, Rosen B, Bahado-Singh RO, Graham SF
Metabolomics. 2018 Nov 24; 14(12)154. doi: 10.1007/s11306-018-1448-3.

PMID:
    30830441
    [PubMed - indexed for MEDLINE]
Related citations


GOG 8020/210: Risk stratification of lymph node metastasis, disease progression and survival using single nucleotide polymorphisms in endometrial cancer: An NRG oncology/gynecologic oncology group study.
Brooks RA, Tritchler DS, Darcy KM, Lankes HA, Salani R, Sperduto P, Guntupalli S, DiSilvestro P, Kesterson J, Olawaiye AB, Moxley K, Waggoner S, Santin A, Rader JS, Kizer NT, Thaker PH, Powell MA, Mutch DG, Birrer MJ, Goodfellow PJ
Gynecol Oncol. 2019 May; 153(2)335-342. doi: 10.1016/j.ygyno.2019.02.028.

PMID:
    30827726
    [PubMed - indexed for MEDLINE]
Related citations


Continuous epidural infusion in gynecologic oncology patients undergoing exploratory laparotomy: The new standard for decreased postoperative pain and opioid use.
Huepenbecker SP, Cusworth SE, Kuroki LM, Lu P, Samen CDK, Woolfolk C, Deterding R, Wan L, Helsten DL, Bottros M, Mutch DG, Powell MA, Massad LS, Thaker PH
Gynecol Oncol. 2019 May; 153(2)356-361. doi: 10.1016/j.ygyno.2019.02.017.

PMID:
    30798950
    [PubMed - indexed for MEDLINE]
Related citations


Inpatient management of hypercalcemia portends a poor prognosis among gynecologic oncology patients: A trigger to initiate hospice care?
Cripe JC, Buchanan TR Jr, Wan L, Hagemann AR, McCourt CK, Massad LS, Fuh KC, Mutch DG, Powell MA, Thaker PH, Kuroki LM
Gynecol Oncol Rep. 2019 May; 281-5. doi: 10.1016/j.gore.2019.01.005.

PMID:
    30733991
    [PubMed]
Related citations

Financial Disclosures

Financial Disclosures

Disclosure of Financial Interests with Industry

Washington University and its physicians and health professionals are committed to ensuring integrity and objectivity in medical decision-making. Some of our physicians and health professionals work collaboratively with pharmaceutical, medical device or other medical care related companies to develop innovative ideas and products that can improve health care delivery and clinical outcomes for patients. In some instances, our physicians and health professionals have an ownership or potential ownership interest in a commercial company; and/or are paid by a commercial company to provide advice on product design or to speak about the use of medications, devices, equipment or procedures. These payments may include: a) compensation for consulting and speaking engagements, b) equity, and/or c) royalties for products invented by our faculty. Any payments to Washington University physicians or health professionals must be based on tangible services and may not exceed fair market value for their work. In addition to disclosure on this website, physicians and health professionals earning more than $10,000 per year must disclose their corporate financial relationship in writing to patients when prescribing or using that company's products.

This physician reported the following financial interests during calendar year 2018:

Company Name: Clovis Oncology

Royalties:

Equity: No

Consulting/Advisory Board:

Speaker Fees: $20,000 - $39,999

Reporting Date: May 01, 2019